Neuropathology of variants of progressive supranuclear palsy

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480

Progressive Supranuclear Palsy

Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930

The `subcortical dementia' of progressive supranuclear palsy

Albert, M. L., Feldman, R. G., & Willis, A. L. (1974) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.37.2.121 · Cited by 871

Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

Hauw, J., Daniel, S. E., Dickson, D. W., Horoupian, D. S., Jellinger, K. A., Lantos, P. L., McKee, A. C., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 854

Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy

Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A. M., Watt, H., Kilford, L., Holton, J. L., Révész, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 747

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

Josephs, K. A. (2006) · Brain · doi:10.1093/brain/awl078 · Cited by 698

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism

Niccolini, F., & Politis, M. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3464-8 · Cited by 50

Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms

Meloni, M., Agliardi, C., Guerini, F. R., Zanzottera, M., Bolognesi, E., Picciolini, S., Marano, M., Magliozzi, A., Fonzo, A. D., Arighi, A., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105947 · Cited by 52

Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration

McMillan, C. T., Toledo, J. B., Avants, B., Cook, P. A., Wood, E. M., Suh, E. R., Irwin, D. J., Powers, J., Olm, C. A., Elman, L. B., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.029 · Cited by 49

On the Use of TMS to Investigate the Pathophysiology of Neurodegenerative Diseases

Rawji, V., Latorre, A., Sharma, N., Rothwell, J. C., & Rocchi, L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.584664 · Cited by 47

Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance

Grimm, M., Respondek, G., Stamelou, M., Arzberger, T., Ferguson, L. W., Gelpí, E., Giese, A., Grossman, M., Irwin, D. J., Pantelyat, A. Y., et al. (2020) · Movement Disorders · doi:10.1002/mds.28263 · Cited by 47

Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy

Pyatigorskaya, N., Yahia‐Cherif, L., Gaurav, R., Ewenczyk, C., Galléa, C., Valabrègue, R., Gargouri, F., Magnin, B., Degos, B., Roze, E. F., et al. (2019) · Movement Disorders · doi:10.1002/mds.27877 · Cited by 49

Progressive Supranuclear Palsy and Corticobasal Degeneration

Dickson, D. W., Hauw, J. J., Agid, Y., & Litvan, I. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch15 · Cited by 48

Experimental investigation into the role of the subthalamic nucleus (STN) in motor control using optogenetics in mice

Guillaumin, A., Serra, G. P., Georges, F. E., & Wallén‐Mackenzie, Å. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147226 · Cited by 48

SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19

Serrano, G. E., Walker, J. E., Tremblay, C., Piras, I. S., Huentelman, M. J., Belden, C. M., Goldfarb, D., Shprecher, D., Atri, A., Adler, C. H., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac056 · Cited by 45

Atypical Parkinsonism

Stamelou, M., & Bhatia, K. P. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.012 · Cited by 45

Progressive supranuclear palsy

Boeve, B. F. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70060-8 · Cited by 43

Recognizing Atypical Parkinsonisms: “Red Flags” and Therapeutic Approaches

Hess, C. W., & McFarland, N. R. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1602422 · Cited by 44

Diffuse Lewy body disease manifesting as corticobasal syndrome

Kasanuki, K., Josephs, K. A., Ferman, T. J., Murray, M. E., Koga, S., Konno, T., Sakae, N., Parks, A. C., Uitti, R. J., van Gerpen, J. A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005828 · Cited by 41

Anti-IgLON 5 Disease

Heidbreder, A., & Philipp, K. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0515-4 · Cited by 42

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes

Schönecker, S., Brendel, M., Palleis, C., Beyer, L., Höglinger, G. U., Schuh, E., Rauchmann, B., Sauerbeck, J., Rohrer, G., Sonnenfeld, S., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00249 · Cited by 44

Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS‐PSP Criteria

Martí‐Andrés, G., van Bommel, L., Meles, S. K., Riverol, M., Valenti‐Azcarate, R., Kogan, R. V., Renken, R. J., Gurvits, V., van Laar, T., Pagani, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28217 · Cited by 42

Progressive supranuclear palsy

Giagkou, N., Höglinger, G. U., & Stamelou, M. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.013 · Cited by 44

Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy

Bruns, M. B., & Josephs, K. A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.766154 · Cited by 41

Communication impairments in people with progressive supranuclear palsy: A tutorial

Kim, J., & McCann, C. (2015) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2015.06.002 · Cited by 40

The pimple sign of progressive supranuclear palsy syndrome

Botha, H., Whitwell, J. L., Madhaven, A., Senjem, M. L., Lowe, V. J., & Josephs, K. A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.10.023 · Cited by 39

Disrupted Resting-State Functional Connectivity in Progressive Supranuclear Palsy

Piattella, M. C., Tona, F., Bologna, M., Sbardella, E., Formica, A., Petsas, N., Filippini, N., Berardelli, A., & Pantano, P. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4229 · Cited by 38

Emerging Diagnostic and Therapeutic Strategies for Tauopathies

Coughlin, D. G., & Irwin, D. J. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0779-1 · Cited by 42

Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease

Pellicano, C., Assogna, F., Cellupica, N., Piras, F., Pierantozzi, M., Stefani, A., Cerroni, R., Mercuri, B., Caltagirone, C., Pontieri, F. E., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.10.002 · Cited by 39

Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy

Whitwell, J. L., Ahlskog, J. E., Tosakulwong, N., Senjem, M. L., Spychalla, A. J., Petersen, R. C., Jack, C. R., Lowe, V. J., & Josephs, K. A. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.12.016 · Cited by 40

Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy

Grijalva, R. M., Pham, N. T. T., Huang, Q., Martin, P. R., Ali, F., Clark, H. M., Duffy, J. R., Utianski, R. L., Botha, H., Machulda, M. M., et al. (2021) · Movement Disorders · doi:10.1002/mds.28901 · Cited by 43

Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia

Graff‐Radford, J., Duffy, J. R., Strand, E. A., & Josephs, K. A. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.04.011 · Cited by 38

Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study

Tomita, S., Oeda, T., Umemura, A., Kohsaka, M., Park, K., Yamamoto, K., Sugiyama, H., Mori, C., Inoue, K., Fujimura, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135823 · Cited by 38

Evidence of corticofugal tau spreading in patients with frontotemporal dementia

Kim, E., Hwang, J., Gaus, S. E., Nana, A. L., Deng, J., Brown, J. A., Spina, S., Lee, M. J., Ramos, E. M., Grinberg, L. T., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02075-z · Cited by 33

Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy

Fujioka, S., Algom, A. A., Murray, M. E., Strongosky, A. J., Soto‐Ortolaza, A. I., Rademakers, R., Ross, O. A., Wszołek, Z. K., & Dickson, D. W. (2013) · Neurology · doi:10.1212/wnl.0b013e318294b2eb · Cited by 36

How to spot ocular abnormalities in progressive supranuclear palsy? A practical review

Phokaewvarangkul, O., & Bhidayasiri, R. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0160-1 · Cited by 39

Extrapyramidal Signs in the Primary Progressive Aphasias

Kremen, S. A., Mendez, M., Tsai, P.-H., & Teng, E. (2011) · American Journal of Alzheimers Disease & Other Dementias · doi:10.1177/1533317510391239 · Cited by 33

18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy

Messerschmidt, K., Barthel, H., Brendel, M., Scherlach, C., Hoffmann, K., Rauchmann, B., Rullmann, M., MAREK, K. L., Villemagne, V. L., Rumpf, J., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262854 · Cited by 35

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid

Boman, A., Svensson, S., Boxer, A. L., Rojas, J. C., Seeley, W. W., Karydas, A., Miller, B. L., Kågedal, K., & Svenningsson, P. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-150759 · Cited by 33

White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study

Zanigni, S., Evangelisti, S., Testa, C. M., Manners, D. N., Buonaura, G. C., Guarino, M., Gabellini, A. S., Gramegna, L. L., Giannini, G., Sambati, L., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.03.001 · Cited by 35

Extrapyramidal Syndromes in Frontotemporal Degeneration

Kertesz, A., McMonagle, P., & Jesso, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9616-1 · Cited by 37

An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability

Kurz, C., Ebersbach, G., Respondek, G., Giese, A., Arzberger, T., & Höglinger, G. U. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0391-7 · Cited by 33

Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review

Ygland, E., van Westen, D., Englund, E. M., Rademakers, R., Wszołek, Z. K., Nilsson, K. H., Nilsson, C., Waldö, M. L., Alafuzoff, I. I., Hansson, O., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0330-2 · Cited by 32

Progressive Supranuclear Palsy and Corticobasal Degeneration

Coughlin, D. G., Dickson, D. W., Josephs, K. A., & Litvan, I. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_11 · Cited by 33

Impairment only on the fluency subtest of the Frontal Assessment Battery after prefrontal lesions.

Chapados, C., & Petrides, M. (2013) · Brain : a journal of neurology · doi:10.1093/brain/awt228 · Cited by 32

The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease

Hendriksz, C. J., Anheim, M., Bauer, P., Bonnot, O., Chakrapani, A., Corvol, J., de Koning, T. J., Degtyareva, А. V., Dionisi‐Vici, C., Doss, S., et al. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1294054 · Cited by 31

The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage

Yoo, H. S., Chung, S. J., Kim, S.-J., Oh, J. S., Kim, J. S., Ye, B. S., Sohn, Y. H., & Lee, P. H. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4019-y · Cited by 30

Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy

Greene, P. E. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000751 · Cited by 32

Aberrant splicing of PSEN2 , but not PSEN1 , in individuals with sporadic Alzheimer’s disease

Course, M. M., Gudsnuk, K. M., Keene, C. D., Bird, T. D., Jayadev, S., & Valdmanis, P. N. (2022) · Brain · doi:10.1093/brain/awac294 · Cited by 33

Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology

Bashir, S., Aiman, A., Shahid, M., Chaudhary, A. A., Sami, N., Basir, S. F., Hassan, M. I., & Islam, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102276 · Cited by 31

Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy

Piattella, M. C., Upadhyay, N., Bologna, M., Sbardella, E., Tona, F., Formica, A., Petsas, N., Berardelli, A., & Pantano, P. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7779-3 · Cited by 29

Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program

Santiago, J. A., Bottero, V., & Potashkin, J. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00157 · Cited by 29

Distinct phosphorylation profiles of tau in brains of patients with different tauopathies

Samimi, N., Sharma, G., Kimura, T., Matsubara, T., Huo, A., Chiba, K., Saito, Y., Murayama, S., Akatsu, H., Hashizume, Y., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.08.011 · Cited by 28

Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders

Sjöström, H., Granberg, T., Hashim, F., Westman, E., & Svenningsson, P. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.08.004 · Cited by 28

“Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonism

Necpál, J., Borsek, M., & Jeleňová, B. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05601-8 · Cited by 28

The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes

Zanigni, S., Testa, C. M., Buonaura, G. C., Sambati, L., Guarino, M., Gabellini, A. S., Evangelisti, S., Cortelli, P., Lodi, R., & Tonon, C. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.025 · Cited by 27

The diagnosis of progressive supranuclear palsy: current opinions and challenges

Ali, F., & Josephs, K. A. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1489241 · Cited by 27

Deep learning reveals disease-specific signatures of white matter pathology in tauopathies

Vega, A. R., Chkheidze, R., Jarmale, V. N., Shang, P., Foong, C., Diamond, M. I., White, C. L., & Rajaram, S. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01271-x · Cited by 27

Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease

Pontieri, F. E., Assogna, F., Stefani, A., Pierantozzi, M., Meco, G., Benincasa, D., Colosimo, C., Caltagirone, C., & Spalletta, G. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.04.023 · Cited by 27

Therapeutic Management of the Overlapping Syndromes of Atypical Parkinsonism

Giagkou, N., & Stamelou, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0551-3 · Cited by 26

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database

Viscidi, E., Litvan, I., Dam, T., Juneja, M., Li, L., Krzywy, H., Eaton, S., Hall, S. A., Kupferman, J., & Höglinger, G. U. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.571800 · Cited by 26

Neuroimaging of Sleep Disturbances in Movement Disorders

Yousaf, T., Pagano, G., Wilson, H., & Politis, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00767 · Cited by 26

Fabry Disease With Concomitant Lewy Body Disease

Tredici, K. D., Ludolph, A. C., Feldengut, S., Jacob, C., Reichmann, H., Böhl, J., & Braak, H. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz139 · Cited by 26

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Poloni, T. E., Medici, V., Carlos, A. F., Davin, A., Ceretti, A., Mangieri, M., Cassini, P., Vaccaro, R., Zaccaria, D., Abbondanza, S., et al. (2020) · Journal of Visualized Experiments · doi:10.3791/60296 · Cited by 28

A data-driven model of brain volume changes in progressive supranuclear palsy

Scotton, W. J., Bocchetta, M., Todd, E. G., Cash, D. M., Oxtoby, N. P., VandeVrede, L. A., Heuer, H. W., Alexander, D. C., Rowe, J. B., Morris, H. R., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac098 · Cited by 28

Clinico‐Pathological Correlation in Progressive Ataxia and Palatal Tremor: A Novel Tauopathy

Mari, Z. K., Halls, A. J. M., Vortmeyer, A. O., Zhukareva, V. A., Uryu, K., Lee, V. M. ‐., & Hallett, M. (2014) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12014 · Cited by 25

The Progressive Supranuclear Palsy: Past and Present Aspects

Parthimos, T. P., & Schulpis, K. H. (2019) · Clinical Gerontologist · doi:10.1080/07317115.2019.1694115 · Cited by 25

A role for the subthalamic nucleus in aversive learning

Serra, G. P., Guillaumin, A., Vlcek, B., Delgado-Zabalza, L., Ricci, A., Rubino, E., Dumas, S., Baufreton, J., Georges, F. E., & Wallén‐Mackenzie, Å. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113328 · Cited by 24

The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy

Alster, P., Otto‐Ślusarczyk, D., Szlufik, S., Duszyńska-Wąs, K., Drzewińska, A., Wiercińska‐Drapało, A., Struga, M., Kutyłowski, M., Friedman, A., & Madetko‐Alster, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-53355-y · Cited by 24

Parkinsonism: heterogeneity of a common neurological syndrome

Kägi, G. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13293 · Cited by 24

Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome

Satoh, R., Weigand, S. D., Pham, N. T. T., Ali, F., Arani, A., Senjem, M. L., Jack, C. R., Whitwell, J. L., & Josephs, K. A. (2023) · Movement Disorders · doi:10.1002/mds.29613 · Cited by 23

Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy

Whitney, K. R., Song, W., Sharma, A., Dangoor, D. K., Farrell, K. W., Krassner, M. M., Ressler, H. W., Christie, T. D., Kandoi, S., Walker, R. H., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02823-w · Cited by 23

SUMO1 Modification of Tau in Progressive Supranuclear Palsy

Takamura, H., Nakayama, Y., Ito, H., Katayama, T., Fraser, P. E., & Matsuzaki, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02734-5 · Cited by 24

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy

Sakae, N., Josephs, K. A., Litvan, I., Murray, M. E., Duara, R., Uitti, R. J., Wszołek, Z. K., Graff‐Radford, N. R., & Dickson, D. W. (2019) · Movement Disorders · doi:10.1002/mds.27816 · Cited by 23

Recognizing and treating atypical Parkinson disorders

Armstrong, M. J., & McFarland, N. R. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00016-9 · Cited by 24

Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [18F]Florzolotau PET imaging and subtype/stage inference algorithm

Hong, J., Lu, J., Liu, F., Wang, M., Li, X., Clement, C., Lopes, L. R., Brendel, M., Rominger, A., Yen, T., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104835 · Cited by 25

The relationship between clinical and pathological variables in Richardson’s syndrome

Schofield, E. C., Hodges, J. R., Bak, T. H., Xuereb, J. H., & Halliday, G. M. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6205-8 · Cited by 22

Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update

Rizzo, G., Zanigni, S., Blasi, R. D., Grasso, D., Martino, D., Savica, R., & Logroscino, G. (2016) · Parkinson s Disease · doi:10.1155/2016/2983638 · Cited by 22

α B ‐crystallin and HSP27 in glial cells in tauopathies

López‐González, I., Carmona, M., Arregui, L., Kovács, G. G., & Ferrer, I. (2014) · Neuropathology · doi:10.1111/neup.12134 · Cited by 21

Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy

Sintini, I., Kaufman, K. R., Botha, H., Martin, P. R., Loushin, S. R., Senjem, M. L., Reid, R. I., Schwarz, C. G., Jack, C. R., Lowe, V. J., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102850 · Cited by 21

Validation of the new pathology staging system for progressive supranuclear palsy

Briggs, M., Allinson, K. S. J., Malpetti, M., Spillantini, M. G., Rowe, J. B., & Kaalund, S. S. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02298-z · Cited by 21

Transcranial brain sonography findings in two main variants of progressive supranuclear palsy

Kostić, V., Mijajlovic, M. D., Smajlović, D., Ječmenica‐Lukić, M., Tomić, A., & Svetel, M. V. (2012) · European Journal of Neurology · doi:10.1111/ene.12034 · Cited by 21

The Role of Vocal Fold Bowing on Cough and Swallowing Dysfunction in Progressive Supranuclear Palsy

Enver, N., Borders, J. C., Curtis, J. A., Sevitz, J. S., Vanegas‐Arroyave, N., & Troche, M. S. (2020) · The Laryngoscope · doi:10.1002/lary.28885 · Cited by 20

Disease course and treatment patterns in progressive supranuclear palsy: A real-world study

Morgan, J. C., Ye, X., Mellor-Bowman, J., Golden, K. J., Zamudio, J., Chiodo, L. A., Bao, Y., & Xie, T. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117293 · Cited by 20

Class A and C GPCR Dimers in Neurodegenerative Diseases

Moreira, I. S., Caniceiro, A. B., Bueschbell, B., & Schiedel, A. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220327221830 · Cited by 18

Tauopathies: Mechanisms and Therapeutic Strategies

Tan, C., Zhang, X.-Y., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170187 · Cited by 21

Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes

Schröter, N., Blazhenets, G., Frings, L., Jost, W. H., Weiller, C., Rijntjes, M., Meyer, P. T., & Brumberg, J. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00392-x · Cited by 19

Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives

Przewodowska, D., Marzec, W. Z., & Madetko‐Alster, N. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.720220 · Cited by 20

The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration

Fodder, K., de Silva, R., Warner, T. T., & Bettencourt, C. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01607-9 · Cited by 22

Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome

Schröter, N., Blazhenets, G., Frings, L., Barkhausen, C., Jost, W. H., Weiller, C., Rijntjes, M., & Meyer, P. T. (2020) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002949 · Cited by 18

Latent trait modeling of tau neuropathology in progressive supranuclear palsy

Kouri, N., Murray, M. E., Reddy, J. S., Serie, D., Soto‐Beasley, A. I., Allen, M., Carrasquillo, M. M., Wang, X., Castanedes, M. C., Baker, M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02289-0 · Cited by 18

Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy

Satoh, R., Ali, F., Botha, H., Lowe, V. J., Josephs, K. A., & Whitwell, J. L. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120509 · Cited by 19

Molecular features of human pathological tau distinguish tauopathy-associated dementias

Kumar, M., Schlaffner, C. N., Tang, S., Beuvink, M. A., Viodé, A., Mair, W., Jha, M., Uncu, C., Wesseling, H., Wang, T., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.036 · Cited by 21

Severe CTE and TDP-43 pathology in a former professional soccer player with dementia: a clinicopathological case report and review of the literature

van Amerongen, S., Kamps, S., Kaijser, K. K. M., Pijnenburg, Y. A. L., Scheltens, P., Teunissen, C. E., Barkhof, F., Ossenkoppele, R., Rozemüller, A. J. M., Stern, R. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01572-3 · Cited by 21

Immediate Effects of Sensorimotor Training in Airway Protection (smTAP) on Cough Outcomes in Progressive Supranuclear Palsy: A Feasibility Study

Borders, J. C., Curtis, J. A., Sevitz, J. S., Vanegas‐Arroyave, N., & Troche, M. S. (2021) · Dysphagia · doi:10.1007/s00455-021-10251-1 · Cited by 17

Optical coherence tomography of patients with Parkinson’s disease and progressive supranuclear palsy

Alkabie, S., Lange, A. P., Manogaran, P., Stoessl, A. J., Costello, F., & Barton, J. J. S. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105635 · Cited by 18

Pathomechanisms of cognitive impairment in progressive supranuclear palsy

Jellinger, K. A. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02613-w · Cited by 16

Diagnostic value of video-oculography in progressive supranuclear palsy: a controlled study in 100 patients

Wunderlich, J., Behler, A., Dreyhaupt, J., Ludolph, A. C., Pinkhardt, E. H., & Kassubek, J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10522-9 · Cited by 16

Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?

de Gordoa, J. S., Zelaya, M. V., Tellechea-Aramburo, P., Acha, B., Roldán, M., López-Molina, C., Coca, V., Galbete, A., Mendióroz, M., & Erro, M. E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.827338 · Cited by 16

Pure akinesia with gait freezing: a clinicopathologic study

Elkouzi, A., Bit‐Ivan, E. N., & Elble, R. J. (2017) · Journal of Clinical Movement Disorders · doi:10.1186/s40734-017-0063-1 · Cited by 16

Cerebellar rTMS in PSP: a Double-Blind Sham-Controlled Study Using Mobile Health Technology

Pilotto, A., Rizzetti, M. C., Lombardi, A., Hansen, C., Biggi, M., Verzeroli, G., Martinelli, A., Romijnders, R., Borroni, B., Maetzler, W., et al. (2021) · The Cerebellum · doi:10.1007/s12311-021-01239-6 · Cited by 15

Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies

Coughlin, D. G., Hiniker, A. O., Peterson, C. S., Kim, Y., Arezoumandan, S., Giannini, L., Pizzo, D. P., Weintraub, D. A., Siderowf, A. D., Litvan, I., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac094 · Cited by 15

Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes

Wattjes, M. P., Huppertz, H., Mahmoudi, N., Stoecklein, S., Rogozinski, S., Wegner, F., Klietz, M., Apostolova, I. I., Levin, J., Katzdobler, S., et al. (2023) · Movement Disorders · doi:10.1002/mds.29527 · Cited by 15

Retina thickness in atypical parkinsonism: a systematic review and meta-analysis

Ma, X., Wang, Y., Wang, N., & Zhang, R. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10703-6 · Cited by 14

Automatic covariance pattern analysis outperforms visual reading of 18F‐fluorodeoxyglucose‐positron emission tomography ( FDG‐PET) in variant progressive supranuclear palsy

Buchert, R., Wegner, F., Huppertz, H., Berding, G., Brendel, M., Apostolova, I. I., Buhmann, C., Dierks, A., Katzdobler, S., Klietz, M., et al. (2023) · Movement Disorders · doi:10.1002/mds.29581 · Cited by 14

Sample size calculations for clinical trials targeting tauopathies: a new potential disease target

Whitwell, J. L., Duffy, J. R., Strand, E. A., Machulda, M. M., Tosakulwong, N., Weigand, S. D., Senjem, M. L., Spychalla, A. J., Gunter, J. L., Petersen, R. C., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7821-5 · Cited by 14

Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant

Ling, H., de Silva, R., Massey, L. A., Courtney, R. J., Hondhamuni, G., Bajaj, N. P. S., Lowe, J. S., Holton, J. L., Lees, A. J., & Révész, T. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12037 · Cited by 97

Progressive supranuclear palsy: what's new?

Lévy, R. (2011) · Gériatrie et Psychologie Neuropsychiatrie du Viellissement · doi:10.1684/pnv.2011.0271 · Cited by 2

202: Severity of tau deposition in progressive supranuclear palsy is associated with clinical phenotype

Williams, D. R., Holton, J. L., Strand, K. M., Pittman, A. M., de Silva, R., Lees, A. J., & Révész, T. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.07.006

Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants

Orlandi, F., Carlos, A. F., Ali, F., Clark, H. M., Duffy, J. R., Utianski, R. L., Botha, H., Machulda, M. M., Stephens, Y. C., Schwarz, C. G., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae113 · Cited by 8

Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy

Koizumi, R., Akagi, A., Riku, Y., Miyahara, H., Sone, J., Tanaka, F., Yoshida, M., & Iwasaki, Y. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106076 · Cited by 8